Qingliang Yang

579 total citations
19 papers, 431 citations indexed

About

Qingliang Yang is a scholar working on Molecular Biology, Immunology and Organic Chemistry. According to data from OpenAlex, Qingliang Yang has authored 19 papers receiving a total of 431 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Immunology and 5 papers in Organic Chemistry. Recurrent topics in Qingliang Yang's work include Neutrophil, Myeloperoxidase and Oxidative Mechanisms (5 papers), Oxidative Organic Chemistry Reactions (4 papers) and Sepsis Diagnosis and Treatment (4 papers). Qingliang Yang is often cited by papers focused on Neutrophil, Myeloperoxidase and Oxidative Mechanisms (5 papers), Oxidative Organic Chemistry Reactions (4 papers) and Sepsis Diagnosis and Treatment (4 papers). Qingliang Yang collaborates with scholars based in United States and China. Qingliang Yang's co-authors include Laurie E. Kilpatrick, Mohammad F. Kiani, Jordan C. Langston, Jón T. Njardarson, Cristian Draghici, Fang Li, Yuan Tang, Harshani Wijerathne, Shuang Sun and Curtis Miyamoto and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and SHILAP Revista de lepidopterología.

In The Last Decade

Qingliang Yang

18 papers receiving 427 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qingliang Yang United States 12 140 122 60 48 40 19 431
Yuyan Bao China 12 111 0.8× 273 2.2× 41 0.7× 26 0.5× 14 0.3× 22 579
Kaitlyn D. Margison Canada 7 134 1.0× 167 1.4× 27 0.5× 20 0.4× 12 0.3× 8 384
Junjie Yang China 14 148 1.1× 188 1.5× 116 1.9× 39 0.8× 9 0.2× 42 564
Sandrine Bacot France 12 56 0.4× 225 1.8× 37 0.6× 27 0.6× 90 2.3× 24 506
Yulia Aleksandrova Russia 12 79 0.6× 280 2.3× 34 0.6× 18 0.4× 33 0.8× 49 502
Ming-Chu Hsieh Taiwan 12 109 0.8× 185 1.5× 38 0.6× 39 0.8× 26 0.7× 17 377
Kaoru Terai United States 14 77 0.6× 254 2.1× 37 0.6× 21 0.4× 16 0.4× 25 477
Peter B. Ehmer Germany 8 86 0.6× 176 1.4× 69 1.1× 9 0.2× 30 0.8× 12 584
Christian Harcken United States 15 290 2.1× 112 0.9× 54 0.9× 21 0.4× 12 0.3× 30 537
Patrick Berna France 12 88 0.6× 313 2.6× 27 0.5× 14 0.3× 20 0.5× 18 505

Countries citing papers authored by Qingliang Yang

Since Specialization
Citations

This map shows the geographic impact of Qingliang Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingliang Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingliang Yang more than expected).

Fields of papers citing papers by Qingliang Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingliang Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingliang Yang. The network helps show where Qingliang Yang may publish in the future.

Co-authorship network of co-authors of Qingliang Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Qingliang Yang. A scholar is included among the top collaborators of Qingliang Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingliang Yang. Qingliang Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Langston, Jordan C., Dan Liu, Qingliang Yang, et al.. (2025). Prioritizing FDA approved therapeutics for treating sepsis phenotypes: A network modeling approach based on neutrophil proteomics. Frontiers in Immunology. 16. 1646141–1646141.
2.
Yang, Qingliang, Jordan C. Langston, Huaqing Zhao, et al.. (2024). Distinct functional neutrophil phenotypes in sepsis patients correlate with disease severity. Frontiers in Immunology. 15. 1341752–1341752. 7 indexed citations
3.
Wang, Chuanyong, Zheng Wang, Jing Zhao, et al.. (2024). Nickel-Catalyzed Enantioselective Alkylation of Primary Phosphines. Journal of the American Chemical Society. 146(40). 27843–27851. 8 indexed citations
4.
Langston, Jordan C., Qingliang Yang, William J. Ohley, et al.. (2022). Omics of endothelial cell dysfunction in sepsis. SHILAP Revista de lepidopterología. 4(1). R15–R34. 16 indexed citations
5.
Langston, Jordan C., Narender Singh, Carmen Merali, et al.. (2022). Molecular Framework of Mouse Endothelial Cell Dysfunction during Inflammation: A Proteomics Approach. International Journal of Molecular Sciences. 23(15). 8399–8399. 8 indexed citations
6.
Langston, Jordan C., Qingliang Yang, Mohammad F. Kiani, & Laurie E. Kilpatrick. (2022). LEUKOCYTE PHENOTYPING IN SEPSIS USING OMICS, FUNCTIONAL ANALYSIS, AND IN SILICO MODELING. Shock. 59(2). 224–231. 5 indexed citations
7.
Yang, Qingliang, Harshani Wijerathne, Jordan C. Langston, Mohammad F. Kiani, & Laurie E. Kilpatrick. (2021). Emerging Approaches to Understanding Microvascular Endothelial Heterogeneity: A Roadmap for Developing Anti-Inflammatory Therapeutics. International Journal of Molecular Sciences. 22(15). 7770–7770. 20 indexed citations
8.
Yang, Qingliang, Jordan C. Langston, Yuan Tang, et al.. (2021). A Microphysiological System to Study Leukocyte-Endothelial Cell Interaction during Inflammation. Journal of Visualized Experiments. 4 indexed citations
9.
Wijerathne, Harshani, Jordan C. Langston, Qingliang Yang, et al.. (2021). Mechanisms of radiation-induced endothelium damage: Emerging models and technologies. Radiotherapy and Oncology. 158. 21–32. 94 indexed citations
10.
Yang, Qingliang, Jordan C. Langston, Yuan Tang, Mohammad F. Kiani, & Laurie E. Kilpatrick. (2019). The Role of Tyrosine Phosphorylation of Protein Kinase C Delta in Infection and Inflammation. International Journal of Molecular Sciences. 20(6). 1498–1498. 44 indexed citations
11.
Soroush, Fariborz, Yuan Tang, Shuang Sun, et al.. (2019). Neutrophil‐endothelial interactions of murine cells is not a good predictor of their interactions in human cells. The FASEB Journal. 34(2). 2691–2702. 12 indexed citations
12.
Tang, Yuan, Fariborz Soroush, Elisabetta Liverani, et al.. (2018). Protein kinase C-delta inhibition protects blood-brain barrier from sepsis-induced vascular damage. Journal of Neuroinflammation. 15(1). 309–309. 55 indexed citations
13.
Yan, Qinying, et al.. (2017). Cyclic guanosine monophosphate-adenosine monophosphate (cGAMP): a novel vaccine adjuvant. Zhonghua weishengwuxue he mianyixue zazhi. 37(10). 790–794. 1 indexed citations
14.
Yang, Qingliang & Jón T. Njardarson. (2013). Base mediated deprotection strategies for trifluoroethyl (TFE) ethers, a new alcohol protecting group. Tetrahedron Letters. 54(51). 7080–7082. 19 indexed citations
15.
Yang, Qingliang, Jón T. Njardarson, Cristian Draghici, & Fang Li. (2013). Total Synthesis of Vinigrol. Angewandte Chemie International Edition. 52(33). 8648–8651. 63 indexed citations
16.
Yang, Qingliang, Cristian Draghici, Jón T. Njardarson, et al.. (2013). Evolution of an oxidative dearomatization enabled total synthesis of vinigrol. Organic & Biomolecular Chemistry. 12(2). 330–344. 31 indexed citations
17.
Yang, Qingliang, Jón T. Njardarson, Cristian Draghici, & Fang Li. (2013). Total Synthesis of Vinigrol. Angewandte Chemie. 125(33). 8810–8813. 19 indexed citations
18.
Yang, Qingliang, Yi Li, Dengfeng Dou, et al.. (2008). Inhibition of serine proteases by a new class of cyclosulfamide-based carbamylating agents. Archives of Biochemistry and Biophysics. 475(2). 115–120. 14 indexed citations
19.
Li, Yi, Qingliang Yang, Dengfeng Dou, Kevin R. Alliston, & William C. Groutas. (2007). Inactivation of human neutrophil elastase by 1,2,5-thiadiazolidin-3-one 1,1 dioxide-based sulfonamides. Bioorganic & Medicinal Chemistry. 16(2). 692–698. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuyan Bao Breakdown of academic impact, for papers by Kaitlyn D. Margison Breakdown of academic impact, for papers by Junjie Yang Breakdown of academic impact, for papers by Sandrine Bacot Breakdown of academic impact, for papers by Yulia Aleksandrova Breakdown of academic impact, for papers by Ming-Chu Hsieh Breakdown of academic impact, for papers by Kaoru Terai Breakdown of academic impact, for papers by Peter B. Ehmer Breakdown of academic impact, for papers by Christian Harcken Breakdown of academic impact, for papers by Patrick Berna
Rankless by CCL
2026